El-Far M - Search Results

1

Antiretroviral therapy-treated HIV-infected adults with coronary artery disease are characterized by a distinctive regulatory T-cell signature.

Rothan C, Yero A, Shi T, Farnos O, Chartrand-Lefebvre C, El-Far M, Costiniuk CT, Tsoukas C, Tremblay C, Durand M, Jenabian MA; Canadian HIV and Aging Cohort Study. Rothan C, et al. AIDS. 2021 Jun 1;35(7):1003-1014. doi: 10.1097/QAD.0000000000002842. AIDS. 2021. PMID: 33587446

2

A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: uroporphyrin I superior to hematoporphyrin derivative.

El-Far M, Pimstone N. El-Far M, et al. Prog Clin Biol Res. 1984;170:661-72. Prog Clin Biol Res. 1984. PMID: 6241706

3

The interaction of tumour-localizing porphyrins with collagen, elastin, gelatin, fibrin and fibrinogen.

el-Far MA, Pimstone NR. el-Far MA, et al. Cell Biochem Funct. 1985 Apr;3(2):115-9. doi: 10.1002/cbf.290030206. Cell Biochem Funct. 1985. PMID: 3836016

4

Selective in vivo tumor localization of uroporphyrin isomer I in mouse mammary carcinoma: superiority over other porphyrins in a comparative study.

el-Far MA, Pimstone NR. el-Far MA, et al. Cancer Res. 1986 Sep;46(9):4390-4. Cancer Res. 1986. PMID: 2942237

5

Tumour localization of uroporphyrin isomers I and III and their correlation to albumin and serum protein binding.

El-Far MA, Pimstone NR. El-Far MA, et al. Cell Biochem Funct. 1983 Oct;1(3):156-60. doi: 10.1002/cbf.290010307. Cell Biochem Funct. 1983. PMID: 6678621

6

Porphyrin:protoporphyrin:plasma protein interaction--the metabolic basis for the tumor localization of hematoporphyrin derivative--a preliminary report.

El-Far M, Pimstone N. El-Far M, et al. Prog Clin Biol Res. 1984;170:657-60. Prog Clin Biol Res. 1984. PMID: 6241705 No abstract available.

7

T-cell exhaustion in HIV infection.

El-Far M, Halwani R, Said E, Trautmann L, Doroudchi M, Janbazian L, Fonseca S, van Grevenynghe J, Yassine-Diab B, Sékaly RP, Haddad EK. El-Far M, et al. Curr HIV/AIDS Rep. 2008 Feb;5(1):13-9. doi: 10.1007/s11904-008-0003-7. Curr HIV/AIDS Rep. 2008. PMID: 18417030 Review.

8

Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection.

Gosselin A, Monteiro P, Chomont N, Diaz-Griffero F, Said EA, Fonseca S, Wacleche V, El-Far M, Boulassel MR, Routy JP, Sekaly RP, Ancuta P. Gosselin A, et al. J Immunol. 2010 Feb 1;184(3):1604-16. doi: 10.4049/jimmunol.0903058. Epub 2009 Dec 30. J Immunol. 2010. PMID: 20042588 Free PMC article.

9

CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction.

Peretz Y, He Z, Shi Y, Yassine-Diab B, Goulet JP, Bordi R, Filali-Mouhim A, Loubert JB, El-Far M, Dupuy FP, Boulassel MR, Tremblay C, Routy JP, Bernard N, Balderas R, Haddad EK, Sékaly RP. Peretz Y, et al. PLoS Pathog. 2012;8(8):e1002840. doi: 10.1371/journal.ppat.1002840. Epub 2012 Aug 16. PLoS Pathog. 2012. PMID: 22916009 Free PMC article. Clinical Trial.

10

Synergistic combinations of the CCR5 inhibitor VCH-286 with other classes of HIV-1 inhibitors.

Asin-Milan O, Sylla M, El-Far M, Belanger-Jasmin G, Haidara A, Blackburn J, Chamberland A, Tremblay CL. Asin-Milan O, et al. Antimicrob Agents Chemother. 2014 Dec;58(12):7565-9. doi: 10.1128/AAC.03630-14. Epub 2014 Sep 29. Antimicrob Agents Chemother. 2014. PMID: 25267674 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page